Anders Berg
Clinical Pathology/Laboratory Medicine · Boston, MANPI 1730251950
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,250 of the $12,938 with a category attached, or 79.2%. Fisher Scientific Company L.L.C. accounts for 79.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $6,375 and has fallen 92.3% since, to $490 in 2025.
Across 15 payments — averaging $862.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fisher Scientific Company L.L.C.$10K
- Diasorin Inc.$2K
- Kaneka Medical America LLC$379
- BD$348
- Abbott$176
- Vertex$125
- plus $160 from 2 others
What the payments were for
- Consulting fees$1,84814%
- Speaking & faculty fees$10,25079%
- Food & beverage$8406%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fisher Scientific Company L.L.C. | 4 | $10,250 |
| Diasorin Inc. | 1 | $1,500 |
| Kaneka Medical America LLC | 1 | $379 |
| BD | 1 | $348 |
| Abbott | 4 | $176 |
| Vertex | 1 | $125 |
| Biocartis US, Inc | 1 | $91 |
| E.r. Squibb & Sons, L.L.C. | 2 | $69 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Procalcitonin$10,250
- MeMed$1,500
- Alinity$139
How this compares
$12,938 in reported general payments places this provider in the 85th percentile of 27 clinical pathology/laboratory medicine providers in Massachusetts.
See all clinical pathology/laboratory medicine providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical pathology/laboratory medicine in Boston
- Christopher StowellBoston$55K
- Matthew MeyersonBoston$22K
- Stacy MelansonBoston$21K
- John HigginsBoston$10K
- Petr JarolimBoston$8K
- Sacha UljonBoston$8K
- Dongsheng XuBoston$6K
- Ileana Lopez PlazaBoston$5K
- Steven SloanBoston$4K
- Agata SmogorzewskaBoston$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.